US Stock MarketDetailed Quotes

Seres Therapeutics (MCRB)

Watchlist
  • 7.760
  • -0.200-2.51%
Close May 13 16:00 ET
75.15MMarket Cap-1.50P/E (TTM)

Seres Therapeutics (MCRB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-160.80%-16.36M
100.75%1.12M
62.17%-14.71M
106.36%2.21M
66.62%-13.29M
176.37%26.91M
-26.63%-148.61M
18.14%-38.88M
41.47%-34.68M
-160.33%-39.81M
Net income from continuing operations
-160.93%-19.91M
4,088.24%5.7M
1.93%-15.34M
-90.76%8.2M
39.60%-19.86M
181.43%32.68M
100.12%136K
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
Operating gains losses
----
99.84%-192K
----
----
----
----
-174,163.38%-123.59M
105.85%24K
-12,089.33%-123.36M
---130K
Depreciation and amortization
-27.42%781K
-24.41%4.13M
-12.07%954K
-25.64%1.04M
-25.42%1.06M
-30.98%1.08M
-12.41%5.47M
-33.52%1.09M
-16.63%1.4M
-7.01%1.42M
Other non cash items
10.27%2.26M
-20.89%8.42M
8.92%2.19M
-26.88%2.13M
-28.13%2.06M
-28.45%2.05M
-29.83%10.64M
-29.08%2.01M
42.38%2.91M
-35.21%2.87M
Change In working capital
89.34%-1.25M
57.59%-27.78M
81.67%-5.52M
-21.43%-11.65M
106.63%1.1M
-27.96%-11.71M
-11.08%-65.51M
-95.76%-30.13M
57.90%-9.59M
-1,036.41%-16.64M
-Change in receivables
140.98%284K
-76.52%1.55M
112.57%260K
-99.44%105K
116.80%1.88M
-155.18%-693K
176.16%6.61M
-125.27%-2.07M
300.05%18.6M
-47.94%-11.18M
-Change in inventory
----
--0
--0
--0
--0
--0
-13.99%-33.8M
--0
20.78%-10.45M
-106.44%-11.02M
-Change in prepaid assets
-1.64%1.32M
175.58%2.72M
-97.38%19K
69.62%-688K
208.72%2.04M
-69.47%1.35M
103.39%987K
102.30%726K
-110.70%-2.27M
-451.40%-1.88M
-Change in payables and accrued expense
96.21%-389K
18.95%-23.38M
86.89%-3.51M
1.95%-8.89M
-107.29%-706K
-287.62%-10.27M
-777.09%-28.84M
-224.48%-26.81M
-100.98%-9.06M
-3.83%9.68M
-Change in other current liabilities
-17.93%-2.47M
-36.84%-8.67M
-15.97%-2.29M
-3.56%-2.18M
-3.48%-2.11M
-859.63%-2.09M
-188.53%-6.34M
-250.89%-1.97M
-99.05%-2.11M
-300.59%-2.04M
-Change in other working capital
----
----
----
----
----
----
-164.39%-4.12M
--0
-168.10%-4.32M
-113.91%-187K
Cash from discontinued investing activities
Operating cash flow
-160.80%-16.36M
100.75%1.12M
62.17%-14.71M
106.36%2.21M
66.62%-13.29M
176.37%26.91M
-26.63%-148.61M
18.14%-38.88M
41.47%-34.68M
-160.33%-39.81M
Investing cash flow
Cash flow from continuing investing activities
0
-100.03%-42K
301.11%181K
-100.01%-8K
-113.90%-181K
45.16%-34K
1,244.67%142.29M
89.74%-90K
7,954.37%141.14M
-87.62%1.3M
Net PPE purchase and sale
--0
88.95%-42K
301.11%181K
93.80%-8K
-82.83%-181K
45.16%-34K
95.24%-380K
89.74%-90K
92.82%-129K
91.97%-99K
Net business purchase and sale
----
--0
--0
----
----
----
--141.27M
--0
----
----
Net investment purchase and sale
----
--0
----
----
----
----
--0
--0
--0
--0
Net other investing changes
----
----
----
----
----
----
--1.4M
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
--0
-100.03%-42K
301.11%181K
-100.01%-8K
-113.90%-181K
45.16%-34K
1,244.67%142.29M
89.74%-90K
7,954.37%141.14M
-87.62%1.3M
Financing cash flow
Cash flow from continuing financing activities
-63.73%428K
115.38%13.9M
628.67%12.66M
100.06%61K
0
-93.71%1.18M
-226.03%-90.37M
-72.98%1.74M
-7,783.37%-110.87M
0
Net issuance payments of debt
----
--0
--0
----
----
----
-353.19%-127.91M
--0
---127.91M
----
Net common stock issuance
-59.84%400K
-44.04%13.17M
600.69%12.17M
--0
--0
-94.59%996K
29.58%23.53M
-72.98%1.74M
--3.38M
--0
Proceeds from stock option exercised by employees
-84.78%28K
50.10%731K
--486K
-54.48%61K
--0
-47.88%184K
-83.92%487K
--0
-90.71%134K
--0
Net other financing activities
----
----
----
----
----
----
--13.52M
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-63.73%428K
115.38%13.9M
628.67%12.66M
100.06%61K
--0
-93.71%1.18M
-226.03%-90.37M
-72.98%1.74M
-7,783.37%-110.87M
--0
Net cash flow
Beginning cash position
37.94%54.43M
-71.02%39.46M
-26.59%56.31M
-33.36%54.05M
-43.55%67.52M
-71.02%39.46M
-20.48%136.15M
-56.94%76.7M
-65.88%81.11M
16.10%119.61M
Current changes in cash
-156.79%-15.93M
115.49%14.97M
94.97%-1.87M
151.25%2.26M
65.02%-13.47M
269.67%28.06M
-175.72%-96.69M
11.23%-37.24M
92.61%-4.41M
-128.59%-38.51M
Effect of exchange rate changes
----
--0
----
----
----
----
-150.00%-1K
---1K
--0
----
End cash Position
-42.97%38.5M
37.94%54.43M
37.94%54.43M
-26.59%56.31M
-33.36%54.05M
-43.55%67.52M
-71.02%39.46M
-71.02%39.46M
-56.94%76.7M
-65.88%81.11M
Free cash flow
-160.87%-16.36M
100.58%865K
62.18%-14.74M
106.31%2.2M
66.25%-13.47M
176.14%26.88M
-18.88%-148.99M
19.44%-38.97M
42.98%-34.81M
-161.64%-39.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -160.80%-16.36M100.75%1.12M62.17%-14.71M106.36%2.21M66.62%-13.29M176.37%26.91M-26.63%-148.61M18.14%-38.88M41.47%-34.68M-160.33%-39.81M
Net income from continuing operations -160.93%-19.91M4,088.24%5.7M1.93%-15.34M-90.76%8.2M39.60%-19.86M181.43%32.68M100.12%136K62.09%-15.64M285.51%88.78M-170.61%-32.87M
Operating gains losses ----99.84%-192K-----------------174,163.38%-123.59M105.85%24K-12,089.33%-123.36M---130K
Depreciation and amortization -27.42%781K-24.41%4.13M-12.07%954K-25.64%1.04M-25.42%1.06M-30.98%1.08M-12.41%5.47M-33.52%1.09M-16.63%1.4M-7.01%1.42M
Other non cash items 10.27%2.26M-20.89%8.42M8.92%2.19M-26.88%2.13M-28.13%2.06M-28.45%2.05M-29.83%10.64M-29.08%2.01M42.38%2.91M-35.21%2.87M
Change In working capital 89.34%-1.25M57.59%-27.78M81.67%-5.52M-21.43%-11.65M106.63%1.1M-27.96%-11.71M-11.08%-65.51M-95.76%-30.13M57.90%-9.59M-1,036.41%-16.64M
-Change in receivables 140.98%284K-76.52%1.55M112.57%260K-99.44%105K116.80%1.88M-155.18%-693K176.16%6.61M-125.27%-2.07M300.05%18.6M-47.94%-11.18M
-Change in inventory ------0--0--0--0--0-13.99%-33.8M--020.78%-10.45M-106.44%-11.02M
-Change in prepaid assets -1.64%1.32M175.58%2.72M-97.38%19K69.62%-688K208.72%2.04M-69.47%1.35M103.39%987K102.30%726K-110.70%-2.27M-451.40%-1.88M
-Change in payables and accrued expense 96.21%-389K18.95%-23.38M86.89%-3.51M1.95%-8.89M-107.29%-706K-287.62%-10.27M-777.09%-28.84M-224.48%-26.81M-100.98%-9.06M-3.83%9.68M
-Change in other current liabilities -17.93%-2.47M-36.84%-8.67M-15.97%-2.29M-3.56%-2.18M-3.48%-2.11M-859.63%-2.09M-188.53%-6.34M-250.89%-1.97M-99.05%-2.11M-300.59%-2.04M
-Change in other working capital -------------------------164.39%-4.12M--0-168.10%-4.32M-113.91%-187K
Cash from discontinued investing activities
Operating cash flow -160.80%-16.36M100.75%1.12M62.17%-14.71M106.36%2.21M66.62%-13.29M176.37%26.91M-26.63%-148.61M18.14%-38.88M41.47%-34.68M-160.33%-39.81M
Investing cash flow
Cash flow from continuing investing activities 0-100.03%-42K301.11%181K-100.01%-8K-113.90%-181K45.16%-34K1,244.67%142.29M89.74%-90K7,954.37%141.14M-87.62%1.3M
Net PPE purchase and sale --088.95%-42K301.11%181K93.80%-8K-82.83%-181K45.16%-34K95.24%-380K89.74%-90K92.82%-129K91.97%-99K
Net business purchase and sale ------0--0--------------141.27M--0--------
Net investment purchase and sale ------0------------------0--0--0--0
Net other investing changes --------------------------1.4M--0--0----
Cash from discontinued investing activities
Investing cash flow --0-100.03%-42K301.11%181K-100.01%-8K-113.90%-181K45.16%-34K1,244.67%142.29M89.74%-90K7,954.37%141.14M-87.62%1.3M
Financing cash flow
Cash flow from continuing financing activities -63.73%428K115.38%13.9M628.67%12.66M100.06%61K0-93.71%1.18M-226.03%-90.37M-72.98%1.74M-7,783.37%-110.87M0
Net issuance payments of debt ------0--0-------------353.19%-127.91M--0---127.91M----
Net common stock issuance -59.84%400K-44.04%13.17M600.69%12.17M--0--0-94.59%996K29.58%23.53M-72.98%1.74M--3.38M--0
Proceeds from stock option exercised by employees -84.78%28K50.10%731K--486K-54.48%61K--0-47.88%184K-83.92%487K--0-90.71%134K--0
Net other financing activities --------------------------13.52M--0--------
Cash from discontinued financing activities
Financing cash flow -63.73%428K115.38%13.9M628.67%12.66M100.06%61K--0-93.71%1.18M-226.03%-90.37M-72.98%1.74M-7,783.37%-110.87M--0
Net cash flow
Beginning cash position 37.94%54.43M-71.02%39.46M-26.59%56.31M-33.36%54.05M-43.55%67.52M-71.02%39.46M-20.48%136.15M-56.94%76.7M-65.88%81.11M16.10%119.61M
Current changes in cash -156.79%-15.93M115.49%14.97M94.97%-1.87M151.25%2.26M65.02%-13.47M269.67%28.06M-175.72%-96.69M11.23%-37.24M92.61%-4.41M-128.59%-38.51M
Effect of exchange rate changes ------0-----------------150.00%-1K---1K--0----
End cash Position -42.97%38.5M37.94%54.43M37.94%54.43M-26.59%56.31M-33.36%54.05M-43.55%67.52M-71.02%39.46M-71.02%39.46M-56.94%76.7M-65.88%81.11M
Free cash flow -160.87%-16.36M100.58%865K62.18%-14.74M106.31%2.2M66.25%-13.47M176.14%26.88M-18.88%-148.99M19.44%-38.97M42.98%-34.81M-161.64%-39.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More